Document:

STOCKHOLDERS’ AGREEMENT

       

      This
Stockholders’ Agreement (this “Agreement”) dated as
of July10, 2009 (the “Effective Date”) is
by and between MyoCardioCare, Inc., a Delaware corporation (“MCC”), and Biophan
Technologies, Inc., a Nevada corporation (“BIOPHAN”).  MCC and BIOPHAN
are individually a “Party”, and together
are the “Parties,” to this
Agreement.

       

      WHEREAS,
MCC has determined that it is in its business interest to acquire certain assets
and intellectual property of BIOPHAN and BIOPHAN has determined it is in its
business interest to sell such assets and Intellectual property to MCC;
and

       

      WHEREAS,
in connection with the sale of assets and intellectual property, BIOPHAN will
receive a 20% ownership interest in MCC;

       

      NOW
THEREFORE, in consideration of the mutual covenants and agreements set forth
herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties agree as
follows:

       

      1.           Rights of First
Refusal.

       

      (a)           After
an initial sale of financing by MCC, which shall take place before December 31,
2009, before any shares of MCC Stock, or any beneficial interest therein, may be
sold, by MCC, such shares shall first be offered to BIOPHAN as set forth
below.

       

      (b)           MCC
shall deliver a notice (the “Notice”) to BIOPHAN stating (i) its intention to
sell securities, (ii) the number of securities proposed to be sold or
transferred (the “Noticed Shares”), and (iii) the price for which it is proposed
to sell or transfer the Noticed Shares and the terms of payment of that price
and other terms and conditions of sale.

       

      (c)           Within
five business days following receipt of the Notice, Biophan must notify MCC in
writing of its intention to purchase all or some of the Noticed Shares (pro rata on the basis
of BIOPHAN’s beneficial ownership interest in MCC at the time of the Notice) on
the same price, terms and conditions set forth in the
Notice.    Biophan shall have thirty (30) days to deliver
the purchase price for the Noticed Shares and complete the closing of the
Noticed Shares.

       

      (d)           In
the case of a transfer of shares of MCC Stock not involving a sale, the fair
market value of the shares shall be determined in good faith by the MCC’s Board
of Directors. Fair market value shall be determined after taking into account
any potential initial public offering or private sale, with no discount for lack
of control, minority interest, marketability, or any other discount. The fair
market value of any Stockholder’s shares shall be such Stockholder’s percentage
interest in the fair market value of the Company as a whole.

       

      (e)           If
BIOPHAN (including any Permitted Assignees) does not elect to purchase the
Noticed Shares, then MCC may sell the Noticed Shares to any purchaser at the
price specified in the Notice or at a higher price, provided that such sale or
transfer is consummated within five (5) months
of the date of the Notice to BIOPHAN.

       

      (f)           MCC
may, at any time prior to the sale, withdraw the Notice.

       

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      2.           Tag-Along_Rights.

       

      (a)           If
MCC, at any time or from time to time, enters into an agreement to sell its
shares in a public offering (a “Tag-Along Sale”), then BIOPHAN shall have the
right, but not the obligation, to participate in such Tag-Along Sale by selling
up to its pro
rata interest (pro rata on the basis
of BIOPHAN’s beneficial ownership interest in MCC at the time of the Tag-Along
Sale)

       

      (b)           Any
such participation by BIOPHAN shall be on the same terms and conditions as the
proposed Tag-Along Sale, including any lock-up provisions.

       

      3.           Miscellaneous.

       

      (a)           No Third Party
Beneficiaries.  Except as specifically provided in this
Agreement, this Agreement shall not confer any rights or remedies upon any
Person other than the Parties and their respective successors and permitted
assigns.

       

      (b)           Entire
Agreement.  Except as agreed to by the Parties in writing, this
Agreement, the Schedules and Exhibits hereto, and the Ancillary Agreements
constitute the entire agreement among the Parties and supersedes any prior
understandings, agreements or representations by or among the Parties, whether
written or oral, with respect to the subject matter hereof.

       

      (c)           Assignment.  No
Party may assign either this Agreement or any of its rights, interests or
obligations under this Agreement without the prior written approval of the other
Parties; provided, however,
that MCC may, without notice to or consent of BIOPHAN, (i) assign all of its
rights and interests and delegate all of its obligations under this Agreement to
a Third Party in connection with the sale of all or substantially all of the
capital stock of MCC or all or substantially all of the assets to which this
Agreement relates (whether by merger, consolidation or otherwise) to such Third
Party, provided that such Third Party executes a counterpart to this Agreement
acknowledging and agreeing to assume all such obligations of MCC and its
Affiliates under this Agreement; (ii) assign all of its rights and interests to
one or more of its Affiliates; (iii) assign right, title and interest in and to
any of the Assigned Intellectual Property Rights to any Party; and (iv)
designate one or more of its Affiliates to perform its obligations under this
Agreement provided that such designation shall not relieve MCC from its
obligations under this Agreement.  Subject to the foregoing, this
Agreement shall be binding upon and inure to the benefit of the Parties named
herein and their respective successors and permitted assigns.

       

      (d)           Counterparts.  This
Agreement may be executed in one or more counterparts, each of which shall be
deemed an original but all of which together shall constitute one and the same
instrument.

       

      (e)           Headings.  The
Section headings contained in this Agreement are inserted for convenience only
and shall not affect in any way the meaning or interpretation of this
Agreement.

       

      
        
           

        

        
          -2-

          
            

          

        

        
           

        

      

      (f)           Notices.  All
communications between BIOPHAN and MCC relating to this Agreement and the
subject matter hereof shall be directed to the persons designated to receive
notices set forth herein or such other individuals as they may
designate.  All notices, requests, demands, claims and other
communications under this Agreement shall be in writing.  Any notice,
request, demand, claim or other communication under this Agreement shall be
deemed duly given (i) when delivered personally to the recipient, (ii) upon
confirmation of facsimile (with a confirmation copy to be sent by overnight
delivery) or (iii) one business day following the date sent when sent by
overnight delivery, at the following address:

       

      If to
BIOPHAN:

      

      BIOPHAN
Technologies, Inc.

      15 Schoen
Place

      Pittsford,
NY 14534

      Attention:  John
Lanzafame, CEO

      

      If to
MCC:

      

      MyoCardioCare,
Inc.

      4165
Taliesin Way

      Fort
Collins, CO 80524-9377

       

      Attention:  Frank
W. Terrizzi, President

       

      Any Party
may change the named individual and address to which notices, requests, demands,
Claims and other communications under this Agreement are to be delivered by
giving the other Party notice in the manner herein set forth.

       

      (g)           Governing
Law.  This Agreement shall be governed by and construed in
accordance with the domestic laws of the State of New York without giving effect
to any choice or conflict of law provision or rule (whether of the State of New
York or any other jurisdiction) that would cause the application of the laws of
any jurisdiction other than the State of New York.  The Parties hereto
submit to the exclusive jurisdiction of the State and Federal courts in the
State of New York and Monroe County with respect to any dispute.

       

      (h)           Amendments and
Waivers.  No amendment of any provision of this Agreement shall
be valid unless the same shall be in writing and signed by MCC and
BIOPHAN.  No waiver by any Party of any provision of this Agreement or
any default, misrepresentation or breach of warranty or covenant under this
Agreement, whether intentional or not, shall be valid unless the same shall be
in writing and signed by the Party making such waiver nor shall such wavier be
deemed to extend to any prior or subsequent default, misrepresentation or breach
of warranty or covenant under this Agreement or affect in any way any rights
arising by virtue of any prior or subsequent such occurrence.  Any
consent, waiver or amendment signed by BIOPHAN shall be deemed the consent,
waiver or amendment of BIOPHAN and its affiliates and any consent, waiver or
amendment signed by a Representative of MCC shall be deemed the consent, waiver
or amendment of MCC’s affiliates pursuant hereto.

       

      
        
           

        

        
          -3-

          
            

          

        

        
           

        

      

      (i)           Severability.  Any
term or provision of this Agreement that is invalid or unenforceable in any
situation in any jurisdiction shall not affect the validity or enforceability of
the remaining terms and provisions hereof or the validity or enforceability of
the offending term or provision in any other situation or in any other
jurisdiction.  In the event that any term or provision of this
Agreement would, under applicable law, be invalid or unenforceable in any
respect, each Party intends that such provision will be construed by modifying
or limiting it so as to be valid and enforceable to the maximum extent
compatible with, and possible under, applicable law.  For any such
invalid or unenforceable provision, the Parties shall use commercially
reasonable efforts to negotiate a substitute valid and enforceable provision
while preserving to the fullest extent possible the intent and agreements of the
Parties set forth herein.

       

      

       

      [Signature
Page Follows]

      
        
           

        

        
          -4-

          
            

          

        

        
           

        

      

      

      IN WITNESS WHEREOF, each of the
undersigned has executed this Agreement as an agreement under seal as of the
date first above written.

       

      
        
          
            	 	

                    MYOCARDIOCARE,
      INC.

                  	 
	 	 	
                     

                     

                  	 
	 	
                    By:
      

                  	/s/Frank
      W. Terrizzi	 
	 	 	

                    Name:
      Frank W. Terrizzi

                  	 
	 	 	

                    Title:
      President

                  	 
	 	 	 	 

          

           

          
            	 	

                    BIOPHAN
      TECHNOLOGIES, INC

                  	 
	 	 	
                     

                     

                  	 
	 	
                    By:
      

                  	/s/ John
      Lanzafame	 
	 	 	

                    Name:
      John Lanzafame

                  	 
	 	 	

                    Title:
      Chief Executive Officer

                  	 
	 	 	 	 

          

        

      

      
        
           

        

        
          -5-Unassociated Document

    
      

       

      WindTamer
Corporation

       

      Stock
Option Award Agreement

       

       

      This
award agreement (this “Award
Agreement”) sets forth the terms and conditions of an award (this “Award”) of
stock options (“Options”)
to purchase with respect to shares (“Shares”)
of Common Stock (“Common
Stock”) granted to you (the "Optionee")
by WindTamer Corporation (the “Company”)
under the WindTamer Corporation 2008 Equity Incentive Plan (the “Plan”).

       

      

      A.           The
Company is a developer of wind turbine power generator technology and is in its
development phase.

      

      B.           Since
_______________, the Optionee has provided services to the Company in connection
with its development and operation.

      

      In
consideration of the covenants set forth in this Agreement, the parties agree as
follows:

      

      1. Option
Information

      

      (a) Date
of Option: _______________

      

      (b)
Optionee: _______________

      

      (c)
Number of Shares: _______________

      

      (d)
Exercise Price: _______________

      

      2. Acknowledgments

      

      (a)
Optionee is [an Employee of/a Consultant to] the Company.

      

      (b) The
Board has authorized the granting to Optionee of a Nonstatutory Option (“Option“)
to purchase Shares of Common Stock upon the terms and conditions hereinafter
stated.

      

      3. Shares; Price

      

      The
Company hereby grants to Optionee the right to purchase, upon and subject to the
terms and conditions herein stated, the number of Shares of Common Stock set
forth in Section 1(c) above at the price per Share set forth in Section 1(d)
above (the “Exercise
Price“), the fair market value per share of the Shares covered by this
Option as of the date of this Option.

       

      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

       

      4. Term of Option

      

      This
Option shall expire, and all rights under it to purchase the Shares, shall
terminate ____________ years from the date of this Award Agreement, unless
terminated earlier pursuant to the terms hereof.  Nothing contained in
this Award Agreement shall be construed to interfere in any way with the right
of the Company to terminate Optionee as [an Employee of/a Consultant to]the
Company, or to increase or decrease the compensation paid to Optionee from the
rate in effect as of the date of this Agreement.

      

      5. Vesting of Option

      

       

      Except as
provided in Paragraph 7, you shall become vested in the Options, and the Options
shall become exercisable, in the following installments on the following dates
(each, a “Vesting
Date”):

       

       

      You shall
become vested in ____% of the Options on the Date of Grant.

       

      6. Exercise

      

      (a) This
Option shall be exercised by delivery to the Company of (a) written notice of
exercise stating the number of Shares being purchased (in whole shares only) and
such other information set forth on the form of Notice of Exercise attached to
this Agreement as Appendix
A, (b) a check or cash in the amount of the Exercise Price of the Shares
covered by the notice (or such other consideration as has been approved by the
Board consistent with the Plan) and (c) a written investment representation as
provided for in Section 13 of this Agreement.

      

      (b)
Pursuant to Section 13 of the Plan, this Option shall not be assignable or
transferable, except by will or by the laws of descent and distribution, or by
gift or domestic relations orders to the Optionee’s Family Members who agree to
be bound by the terms of this Agreement. "Family Member" for purposes of this
Agreement, includes any child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law,
including adoptive relationships, any person sharing the employee's household
(other than a tenant or employee), a trust in which these persons have more than
fifty percent of the beneficial interest, a foundation in which these persons
(or the employee) control the management of assets, and any other entity in
which these persons (or the employee) own more than fifty percent of the voting
interests.

      

      7. Termination of
Service

      

      If
Optionee's service as [an Employee of/a Consultant to] the Company terminates
for any reason, no further installments shall vest pursuant to Section 5, and
Optionee shall have the right at any time within 120 days following such
termination of services or the remaining term of this Option, whichever is the
lesser, to exercise in whole or in part this Option to the extent, but only to
the extent, that this Option was exercisable as of the date Optionee ceased to
be [an Employee of/a Consultant to] the Company; provided, however, if Optionee
is terminated for reasons that would justify a termination “for cause” or if
Optionee violates any provision of Paragraph 15 of this Award Agreement, the
foregoing right to exercise shall automatically terminate on such date as to all
Shares covered by this Option not exercised prior to such termination or
violation, as the case might be. Unless earlier terminated, all rights under
this Award Agreement shall terminate in any event on the expiration date of this
Option as defined in Section 4 of this Agreement.

       

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

       

      8. Death of Optionee

      

      If the
Optionee shall die while serving as [an Employee of/a Consultant to] the
Company, Optionee's personal representative or the person entitled to Optionee's
rights hereunder may at any time within 120 days after the date of Optionee's
death, or during the remaining term of this Option, whichever is the lesser,
exercise this Option and purchase Shares to the extent, but only to the extent,
that Optionee could have exercised this Option as of the date of Optionee's
death; provided, in any case, that this Option may be so exercised only to the
extent that this Option has not previously been exercised by
Optionee.

      

      9. No Rights as
Shareholder

      

      Optionee
shall have no rights as a shareholder with respect to the Shares covered by any
installment of this Option until the effective date of the issuance of shares
following exercise of this to Option, and no adjustment will be made for
dividends or other rights for which the record date is prior to the date such
stock certificate or certificates are issued except as provided in Section 10 of
this Agreement.

      

      10. Recapitalization; Dissolution or
Change in Control

      

      (a)
Subject to any required action by the shareholders of the Company, the number of
Shares covered by this Award Agreement, and the Exercise Price thereof, shall be
proportionately adjusted as provided in Section 14(a) of the Plan.

      

      (b) In
the event of a proposed dissolution or liquidation of the Company, this Award
Agreement shall be governed by Section 14(b) of the Plan.

      

      (c) In
the event of a Change in Control of the Company, this Award Agreement shall be
governed by Section 14(c) of the Plan.

      

      (d) The
grant of this Award Agreement shall not affect in any way the right or power of
the Company to make adjustments, reclassifications, reorganizations or changes
in its capital or business structure or to merge, consolidate, dissolve or
liquidate or to sell or transfer all or any part of its business or
assets.

       

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

       

      11. Taxation Upon Exercise of
Option

      

      Optionee
understands that, upon exercise of this Option, Optionee will recognize income,
for Federal and state income tax purposes, in an amount equal to the amount by
which the fair market value of the Shares, determined as of the date of
exercise, exceeds the Exercise Price. The acceptance of the Shares by Optionee
shall constitute an agreement by Optionee to report such income in accordance
with then applicable law and to cooperate with Company in establishing the
amount of such income and corresponding deduction to the Company for its income
tax purposes. Withholding for federal or state income and employment tax
purposes will be made, if and as required by law, from Optionee's then current
compensation, or, if such current compensation is insufficient to satisfy
withholding tax liability, the Company may require Optionee to make a cash
payment to cover the liability as a condition of the exercise of this
Option.

      

      12. Modification, Extension and Renewal
of Options

      

      The Board
or a Committee thereof may modify, extend or renew this Option or accept its
surrender (to the extent not yet exercised) and authorize the granting of a new
option in substitution for it (to the extent not yet exercised), subject at all
times to the Code and New York law.  Notwithstanding the provisions of
this Section 12, no modification shall, without the consent of the Optionee,
alter to the Optionee's detriment or impair any rights of Optionee hereunder,
except for the Board’ authority to make adjustments as provided in Section
10.

      

      13. Investment Intent; Restrictions on
Transfer

      

      (a)
Optionee represents and agrees that if Optionee exercises this Option in whole
or in part, Optionee will in each case acquire the Shares upon such exercise for
the purpose of investment and not with a view to, or for resale in connection
with, any distribution thereof; and that upon the exercise of this Option in
whole or in part, Optionee (or any person or persons entitled to exercise this
Option under the provisions of Sections 7 and 8 of this Award Agreement) shall
furnish to the Company a written statement to such effect, satisfactory to the
Company in form and substance.

      

      (b)
Optionee further represents that Optionee has had access to the financial
statements or books and records of the Company, has had the opportunity to ask
questions of the Company concerning its business, operations and financial
condition. Optionee further represents to obtain additional information
reasonably necessary to verify the accuracy of such information, and further
represents that Optionee (either alone or in conjunction with his or her
professional advisers) has such experience in and knowledge of investment,
financial and business matters with respect to investments similar to the stock
of the Company that Optionee is capable of evaluating the merits and risks
thereof and has the capacity to protect his or her own interest in connection
therewith.

       

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

       

      (c)
Unless and until the Shares represented by this Option are registered under the
Securities Act, all certificates representing the Shares and any certificates
subsequently issued in substitution therefore and any certificate for any
securities issued pursuant to any stock split, share reclassification, stock
dividend or other similar capital event shall bear legends in substantially the
following form:

      

      THESE
SECURITIES HAVE NOT BEEN REGISTERED OR OTHERWISE QUALIFIED UNDER THE SECURITIES
ACT OF 1933 (THE “SECURITIES
ACT“) OR UNDER THE APPLICABLE SECURITIES LAWS OF ANY STATE. NEITHER THESE
SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR
OTHERWISE DISPOSED OF IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR
ANY APPLICABLE SECURITIES LAWS OF ANY STATE, UNLESS PURSUANT TO EXEMPTIONS
THEREFROM.

      

      The
certificates shall bear such other legend or legends as the Company and its
counsel deem necessary or appropriate. Appropriate stop transfer instructions
with respect to the Shares have been placed with the Company's transfer
agent.

      

      14. Stand-Off
Agreement

      

      Optionee
agrees that, in connection with any registration of the Company's securities
under the Securities Act, and upon the request of the Company or any underwriter
managing an underwritten offering of the Company's securities, Optionee shall
not sell, short any sale of, loan, grant an option for, or otherwise dispose of
any of the Shares (other than Shares included in the offering) without the prior
written consent of the Company or such managing underwriter, as applicable, for
a period of up to two years following the effective date of registration of such
offering.

      

      15. Confidentiality; Non-Solicitation;
Intellectual Property.  As a material inducement to the Company
to grant this Option and to enter into this Agreement, the Optionee hereby
expressly agrees to be bound by the following covenants, terms and
conditions:

      

      (a)
During the course of the Optionee's relationship with the Company or any of its
affiliates, the Optionee has had, and will have, access to Confidential
Information relating to the Company and its affiliates and their respective
suppliers, partners and customers. The Optionee agrees to keep secret and retain
in strictest confidence all of such Confidential Information, and will not
disclose, disseminate or use such information for the Optionee's own advantage
or for the advantage of any other person or entity other than the Company in
accordance with the terms of the Optionee's employment or relationship with the
Company.  In the event disclosure of any such Confidential Information
is required or purportedly required by law, the Optionee will provide the
Company with prompt notice of any such requirement so that the Company may seek
an appropriate protective order prior to disclosure.

       

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

       

      (b) In
the event that the Optionee as part of his activities on behalf of the Company
generates, creates, authors or contributes to any invention, design, new
development, device, product, method or process (whether or not patentable or
reduced to practice or constituting Confidential Information), any copyrightable
work (whether or not constituting Confidential Information) or any other form of
Confidential Information relating directly or indirectly to the Company's
business (including anything that has occurred since the first date Optionee
provided services to the Company), the Optionee acknowledges that such
Intellectual Property is the exclusive property of the Company and hereby
assigns all right, title and interest in and to such Intellectual Property to
the Company.  Any copyrightable work prepared in whole or in part by
the Optionee is and will be deemed "a work made for hire" under Section 201(b)
of the 1976 Copyright Act, and the Company shall own all of the rights comprised
by the copyright therein.  The Optionee shall promptly and fully
disclose all Intellectual Property to the Company and shall cooperate with the
Company to protect the Company's interests in and rights to such Intellectual
Property (including, without limitation, providing reasonable assistance in
securing patent protection and copyright registrations and executing all
documents as reasonably requested by the Company, whether such requests occur
prior to or after termination of the Optionee's employment with the
Company).  Notwithstanding the Date of Option or anything else herein
to the contrary, the provisions of this Section 15(b) shall be deemed to be
effective as of and apply to all matters occurring since the first date Optionee
provided services to the Company.

      

      (c) As
requested by the Company from time to time for any reason, the Optionee shall
promptly deliver to the Company all copies and embodiments, in whatever form, of
all Confidential Information and Intellectual Property in the Optionee's
possession or within his control (including, but not limited to, written
records, notes, photographs, manuals, notebooks, documentation, program
listings, flow charts, magnetic media, disks, diskettes, tapes and all other
materials containing any Confidential Information or Intellectual Property)
irrespective of the location or form of such material and, if requested by the
Company, shall provide the Company with written confirmation that all such
materials have been delivered to the Company.

      

      (d) The
Optionee acknowledges that in the event the Optionee violates any provisions of
this Section 15, in addition to its other rights and remedies, the Company shall
be entitled to injunctive relief without the necessity of proving actual
damages.  The Optionee further acknowledges that if any provision of
this Section 15 is held to be unenforceable, the court making such holding shall
have the power to modify such provision and in its modified form such provision
shall be enforced.

      

      (e)
Without in any way limiting the provisions of this Section 15, the Optionee
further acknowledges and agrees that the provisions of this Section 15 shall
remain applicable in accordance with their terms after the termination or
cessation of services to the Company or exercise or termination of the
Option.

      

      (f)
"Confidential Information" means information or material proprietary to the
Company or designated as Confidential Information by Company and not generally
known by non-Company personnel, which the Optionee develops, or of which
Optionee obtains knowledge, or to which the Optionee may obtain access, through
or as a result of, the Optionee's relationship with the Company (including
information conceived, originated, discovered or developed in whole or in part
by the Optionee).  Confidential Information includes, but is not
limited to, the following types of information and other information of a
similar nature (whether or not reduced to writing): discoveries, ideas,
concepts, software in various stages of development, designs, drawings,
specifications, techniques, models, data, source code, object code, data
structures, instruction sets, documentation, diagrams, flow charts, research,
development, training methods, training manuals, processes, procedures,
"know-how," marketing techniques and materials, marketing and development plans,
customer names and other information related to customers, price lists, pricing
policies and financial information.  Confidential information also
includes any information described above which the Company obtains from other
entities and which the Company treats as proprietary or designates as
Confidential Information, whether or not owned or developed by the
Company.  Notwithstanding the foregoing, information publicly known
that is generally employed by the trade at or after the time Optionee first
learns of such information, or generic information or knowledge which associate
would have learned in the course of similar employment or work elsewhere in the
trade, shall not be deemed part of the confidential information.

       

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

       

      (g)
"Intellectual Property" shall mean those forms of authorship (as understood from
Title 17 of the United States Code), invention (as understood by Title 35 of the
United States Code) and identification (as understood from Title 15 of the
United States Code Section 1051 et seq., trademarks and service marks) and such
other forms of property rights in ideas, "know how," inventions, discoveries, or
in their physical embodiments as shall related to or involve the Company's
business or any of its products, services or strategies.

      

      16. Notices

      

      Any
notice required to be given pursuant to this Option or the Plan shall be in
writing and shall be deemed to be delivered upon receipt or, in the case of
notices by the Company, 3 days after deposit in the U.S. mail, postage prepaid,
addressed to Optionee at the address last provided by Optionee for use in
Company records related to Optionee.

      

      17. Applicable Law

      

      This
Option has been granted, executed and delivered in the State of New York, and
the interpretation and enforcement shall be governed by the laws thereof and
subject to the exclusive jurisdiction of the courts therein.

       

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

       

      

      IN WITNESS WHEREOF, the
parties hereto have executed this Option as of the date first above
written.

      

      

      WindTamer
Corporation

      

      

      _________________________________

      By:

      Title:

      

      Optionee

      

      

      ___________________________

      Name:

      
        
          	
                  Address:

                	
                  _______________

                
	 
      	
                  _______________

                
	
                  SS#:

                	
                  _______________

                

        

      

       

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

       

      
 

      APPENDIX
A

      

      NOTICE
OF EXERCISE OF STOCK OPTION

      

      To:           Future
Energy Solutions, Inc.

      

      The undersigned is a holder of a stock
option (the "Option")
to purchase shares of WindTamer Corporation (the "Company")
Common Stock, $.0001 par value per share (the "Common
Stock"), issued pursuant to a WindTamer Corporation Stock Option Award
Agreement dated as of December 16, 2008 (the "Agreement").  A
copy of the Agreement evidencing such Option is annexed hereto.

      

      The undersigned hereby elects to
purchase ____________ shares of Common Stock pursuant to the terms of such
Option (the "Option
Shares"), and tenders herewith payment in full in the amount of $________
per share, for a total purchase price of $_______________, with the payment of
the purchase price being made in the form of _____________________, pursuant to
Section 6 of the Agreement.  The undersigned wishes to consummate the
purchase of the Option Shares by or before ________________.

      

      In exercising his Option, the
undersigned hereby confirms and acknowledges that he is acquiring Option Shares
for his own account for investment and not with a view to, or for sale in
connection with, the resale or distribution of any such shares.  The
undersigned also confirms and acknowledges that he will not sell or transfer any
Option Shares acquired pursuant to the exercise of the Option until he requests
and receives an opinion of the Company's counsel to the effect that such
proposed sale or transfer will not result in a violation of the Securities Act
of 1933, as amended, or any applicable state securities law, or a registration
statement covering the sale or transfer of the Option Shares has been declared
effective by the Securities and Exchange Commission or appropriate state
governmental authority, or he obtains a no-action letter from the Securities and
Exchange Commission or appropriate state governmental authority with respect to
the proposed transfer.

      

      The undersigned acknowledges and agrees
that this purported exercise of the Option is conditioned on, and subject to,
(a) any compliance with requirements of applicable federal and state securities
laws deemed necessary by the Company, (b) to the undersigned's satisfaction of
all federal, state or local income and employment tax withholding requirements
applicable to this exercise, and (c) if the exercise is made in connection with
a Change of Control transaction, the vesting of the Option Shares may be
conditioned upon the consummation of the Change of Control if the Committee has
provided for this condition in its acceleration of the Option.

      

      Please issue a certificate or
certificates representing said Option Shares in the name of the undersigned or
in such other name as is specified below.  If the Option Shares are
being issued to any person other than the Optionee, evidence of the right of
such person to exercise the Option has been presented to the Company and has
been deemed satisfactory:

      

      

      
        
          
            
              
                
                  	 
      	 
      	    
      
	 
      	
                           

                        	      
                          Name

                        
	 
      	
                          Address:

                        	    
      
	 
      	 
      	    
      
	 
      	 
      	 
      
	 
      	 
      	    
      
	 
      	
                           

                        	      
                          Social
      Security Number

                        
	 
      	 
      	 
      
	 
      	
                          Date:

                        	    
      

                

              

            

          

        

      

       

       

      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

       

      

      SCHEDULE
TO EXHIBIT 10.15 – FORM OF STOCK OPTION AWARD AGREEMENT UNDER THE 2008 EQUITY
INCENTIVE PLAN

      

      The Form
of WindTamer Corporation Stock Option Award Agreement under the 2008 Equity
Incentive Plan filed as Exhibit 10.15 is substantially identical in all material
respects to the Stock Options Award Agreements which have been entered into by
the non-employee consultants of WindTamer Corporation, Bruce C. Caruana and
Ronald Reding, except as set forth below:

      

      
        
          
            	
                    Date of

                    Agreement

                  	
                     

                    Name of Optionee

                  	
                    # of

                    Shares

                  	
                     

                    Exercise Price

                  	
                     

                    Vesting

                  	
                     

                    Term

                  
	 
      	 
      	 
      	 
      	 
      	 
      
	
                    12/16/08

                  	
                    Bruce
      C. Caruana

                  	
                    200,000

                  	
                    $.05

                  	
                    100%

                  	
                    3
      years

                  
	
                    12/18/08

                  	
                    Ronald
      Reding

                  	
                    200,000

                  	
                    $.05

                  	
                    100%

                  	
                    3
      years

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]